U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
The Parent Company was added by ICIJ.
The parent company information is based on 2017 public records.
데이터 추가 비고
Radioimmunoassay, testosterones and dihydrotestosterone - Product Code CDZ
원인
Qualigen initiated this recall because the fastpack kit may cause lower than expected results due to a manufacturing defect.
조치
Qualigen, Inc., notified customers of the recall by calling customers via telephone (with a telephone script) on 11/08/2013. The telephone (script) included the reason for recall, product description with codes, instructions and contact information. The customers were instructed to examine your inventory and discontinue use of the kits immediately. Qualigen will send you
replacement kits and provide you with a shipping label to return all of the defective kits including any that were partially used.
Feel free to contact System Support at 760.579.6900 if you have any
questions or require assistance with returning your kits.
US Distribution to states of: AL, CA, KS, KY, IN, MA, NC, NY, NV, OK, SC, TN, TX, UT, VA, and WA.
제품 설명
FastPack Testosterone Immunoassay || Chemilunescence assay for the determination of Testosterone || The FastPack Testo Immunoassay is a paramagnetic particle immunoassay for the in vitro quantitative determination of total testosterone in human serum and plasma. It is intended strictly for in-vitro diagnostic use as an aid in the diagnosis and management of conditions involving excess or deficiency of this androgen. The FastPack Testo Immunoassay is designed for use with the FastPack System.